Transcelerate Biopharma INC's annual revenue was $34.2M in tax year 2025, reported on their IRS Form 990. They spent $33.0M in total expenses. 67% went to programs and services.
Transcelerate Biopharma INC spent $33.0M in tax year 2025, according to their IRS Form 990 filing.
Transcelerate Biopharma INC spent $22.0M (67% of expenses) on programs and services in tax year 2025.
Transcelerate Biopharma INC's overhead in tax year 2025 includes administrative (33%) of their expenses.
Transcelerate Biopharma INC had net assets of $19.7M as of the end of tax year 2025.
Track Transcelerate Biopharma INC
Follow to get their new filings, financial changes and grants as they post.
Leave your email and we’ll let you know when you can finish signing in and follow the organization.
Try signing in anyway →